What is the primary revenue source for Doximity (DOCS)?

According to the latest financial reports, the company's revenue is driven by its core business segments and operational services. You can explore the exact breakdown and proportions of each revenue stream using the interactive charts on this page.

How can I visualize and analyze DOCS's financial statements?

gkcal provides interactive Sankey diagrams and profit waterfall charts that map out Doximity's total revenue, cost of goods sold, operating expenses, and net income, making it easy to understand their business model and cash flow at a glance.

How Doximity Makes Money: DOCS Revenue Breakdown (2026)

Income Statement – DOCS FY 2026 Income Statement (FY 2026)

Income Statement FY 2026
Item	Category	Value	YoY
Revenue	revenue	644.86M	13.05%
Gross profit	profit	574.54M	11.66%
Cost of revenue	cost	70.33M	25.87%
Other income, net	revenue	35.09M	-1.93%
Income from operations	profit	214.92M	-5.65%
Total operating expenses	cost	359.62M	25.42%
Income before income taxes	profit	250.00M	-5.15%
Sales and marketing	cost	163.65M	12.31%
Research and development	cost	130.70M	40.48%
General and administrative	cost	65.27M	42.91%
Net income	profit	196.05M	-12.16%
Provision for income taxes	cost	53.95M	33.59%

Products Breakdown
Segment	Value	YoY
Subscription	608.41M	11.89%
Service, Other	36.45M	36.88%

Balance Sheet – DOCS FY 2026 Balance Sheet (FY 2026)

Balance Sheet FY 2026
Item	Category	Value	YoY
Marketable securities	assets	529.42M	-25.02%
Cash and cash equivalents	assets	219.18M	4.56%
Accounts receivable, net of allowance for doubtful accounts of $1,345 and $1,937 as of march 31, 2026 and 2025, respectively	assets	144.78M	12.80%
Prepaid expenses and other current assets	assets	50.88M	14.08%
Total current assets	assets	944.26M	-13.26%
Goodwill	assets	84.97M	25.07%
Intangible assets, net	assets	35.33M	53.11%
Deferred income tax assets	assets	31.98M	-46.71%
Property and equipment, net	assets	18.08M	32.40%
Operating lease right-of-use assets	assets	7.14M	-19.65%
Other assets	assets	1.92M	-9.43%
Total assets	assets	1.12B	-11.12%
Total liabilities	liabilities	172.85M	-4.86%
Total stockholders' equity	equity	950.84M	-12.17%
Retained earnings (accumulated deficit)	equity	51.06M	-72.68%
Total current liabilities	liabilities	154.97M	-0.82%
Other liabilities, non-current	liabilities	9.40M	0.20%
Operating lease liabilities, non-current	liabilities	8.07M	-20.72%
Deferred revenue, non-current	liabilities	400000	42.86%
Aggregate	equity	1.00B
Deferred revenue, current	liabilities	106.05M	-7.21%
Accrued expenses and other current liabilities	liabilities	42.80M	11.45%
Accounts payable	liabilities	4.01M	195.65%
Operating lease liabilities, current	liabilities	2.11M	-4.57%
Additional paid-in capital	equity	1.00B	12.02%
Class a and class b common stock, $0.001 par value; 1,500,000 shares authorized as of march 31, 2026 and 2025, respectively; 183,060 and 188,875 shares issued and outstanding as of march 31, 2026 and 2025, respectively	equity	183000	-3.17%
Accumulated other comprehensive income	equity	28000	-97.88%

Cash Flow Statement – DOCS 12M 2026 Cash Flow Statement (12M 2026)

Operating Activities – 12M 2026
Item	Value
Net income	196.05M
Stock-based compensation, net of amounts capitalized	121.63M
Deferred income taxes	32.14M
Depreciation and amortization	14.38M
Amortization of deferred contract costs	13.48M
Accounts payable, accrued expenses and other liabilities	4.27M
Non-cash lease expense	1.75M
Other noncash income (expense)	314000
Operating lease liabilities	-2.21M
Accretion (amortization) of discounts and premiums, investments	-7.58M
Deferred revenue	-8.12M
Increase (decrease) in prepaid expense and other assets	-8.27M
Increase (decrease) in capitalized contract cost	-14.49M
Increase (decrease) in accounts receivable	-16.88M

Investing Activities – 12M 2026
Item	Value
Maturities of marketable securities	561.43M
Sales of marketable securities	10.39M
Payments to acquire intangible assets	-62000
Payments to develop software	-8.90M
Payments to acquire businesses, net of cash acquired	-26.53M
Payments to acquire debt securities, available-for-sale	-389.16M

Financing Activities – 12M 2026
Item	Value
Proceeds from issuance of common stock upon exercise of stock options and common stock warrants	9.78M
Proceeds from issuance of common stock in connection with the employee stock purchase plan	3.89M
Payment for contingent consideration liability, financing activities	-5.25M
Payment, tax withholding, share-based payment arrangement	-40.84M
Payments for repurchase of common stock	-431.65M

Cash Balance – 12M 2026
Item	Value
Cash and cash equivalents, beginning of period	209.61M
Cash and cash equivalents, end of period	219.18M

Income Statement – DOCS FY 2026 Income Statement (FY 2026)

Balance Sheet – DOCS FY 2026 Balance Sheet (FY 2026)

Cash Flow Statement – DOCS 12M 2026 Cash Flow Statement (12M 2026)

Financial Insights

Please select a report to view